Staphylococci: Colonizers and pathogens of human skin

Future Microbiology

Volumn 9, Issue 1, 2014, Pages 75-91

  Coates, Rosanna ^a   Moran, Josephine ^a   Horsburgh, Malcolm J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

adhesin; antimicrobial peptide; commensal; desiccation; fatty acid; pathogen; skin colonization; sphingosine; Staphylococcus

Indexed keywords

ADENOSINE PHOSPHATE; ADHESIN; ARGININE; COLLAGEN TYPE 1; CYTOKERATIN 10; FIBRINOGEN; FIBRONECTIN; GLYCOLIPID; INVOLUCRIN; LORICRIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; RIBONUCLEASE; RIBONUCLEASE 5; RIBONUCLEASE 7; RIBONUCLEASE A; SPHINGOSINE; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; DESICCATION; EPIDERMIS; KERATINOCYTE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SKIN; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRESS; TISSUE SPECIFICITY;

CARRIER STATE; HOST-PATHOGEN INTERACTIONS; HUMANS; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

EID: 84890580030     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.145     Document Type: Review

References (164)

1. Cogen A, Nizet V, Gallo R. Skin microbiota: A source of disease or defence?. Br. J. Dermatol. 158(3), 442-455 (2008).
2. Zeeuwen P, Boekhorst J, van den Bogaard E et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 13(11), R101 (2012).
3. Grice E, Kong H, Conlan S et al. Topographical and temporal diversity of the human skin microbiome. Science 324(5931), 1190-1192 (2009).
4. Gao Z, Tseng C, Pei Z, Blaser M. Molecular analysis of human forearm superficial skin bacterial biota. Proc. Natl Acad. Sci. USA 104(8), 2927-2932 (2007).
5. Taylor D, Daulby A, Grimshaw S, James G, Mercer J, Vaziri S. Characterization of the microflora of the human axilla. Int. J. Cosmetic Sci. 25(3), 137-145 (2003).
6. Costello E, Lauber C, Hamady M, Fierer N, Gordon J, Knight R. Bacterial community variation in human body habitats across space and time. Science 326(5960), 1694-1697 (2009).
7. Capone K, Dowd S, Stamatas G, Nikolovski J. Diversity of the human skin microbiome early in life. J. Invest. Dermatol. 131(10), 2026-2032 (2011).
8. Somerville D. Normal flora of skin in different age groups. Br. J. Dermatol. 81(4), 248-258 (1969).
9. Oh J, Conlan S, Polley E, Segre J, Kong H. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 4(10), 77 (2012).
10. Frank D, Feazel L, Bessesen M, Price C, Janoff E, Pace N. The human nasal microbiota and Staphylococcus aureus carriage. PLoS ONE 5(5), e10598 (2010).
11. Kluytmans J, Wertheim H. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 33(1), 3-8 (2005).
12. Moss B, Squire J. Nose and skin carriage of Staphylococcus aureus in patients receiving penicillin. Lancet 1(6496), 320-325 (1948).
13. Cherifi S, Byl B, Deplano A, Nonhoff C, Denis O, Hallin M. Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers. J. Clin. Microbiol. 51(5), 1541-1547 (2013).
14. Cho J, Xuan C, Miller L. Lucky number seven: RNase 7 can prevent Staphylococcus aureus skin colonization. J. Invest. Dermatol. 130(12), 2703-2706 (2010).
15. von Eiff C, Becker K, Machka K, Stammer H, Peters G, Study G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344(1), 11-16 (2001).
16. Segre J. Epidermal differentiation complex yields a secret: Mutations in the cornification protein filaggrin underlie ichthyosis vulgaris. J. Invest. Dermatol. 126(6), 1202-1204 (2006).
17. Blanpain C, Fuchs E. Epidermal homeostasis: A balancing act of stem cells in the skin. Nat. Rev. Mol. Cell Biol. 10(3), 207-217 (2009).
18. Jonca N, Leclerc E, Caubet C, Simon M, Guerrin M, Serre G. Corneodesmosomes and corneodesmosin: From the stratum corneum cohesion to the pathophysiology of genodermatoses. Eur. J. Dermatol. 21, 35-42 (2011).
19. Rice R, Green H. Cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein. Cell 11(2), 417-422 (1977).
20. Schmitz G, Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J. Lipid Res. 32(10), 1539-1570 (1991).
21. Candi E, Schmidt R, Melino G. The cornified envelope: A model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 6(4), 328-340 (2005).
22. Watt F, Fujiwara H. Cell-extracellular matrix interactions in normal and diseased skin. Cold Spring Harb. Perspect. Biol. 3(4), doi:10.1101/cshperspect. a005124 (2011).
23. Iwai I, Han H, den Hollander L et al. The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moiety. J. Invest. Dermatol. 132(9), 2215-2225 (2012).
24. Grice E, Kong H, Renaud G et al. A diversity profile of the human skin microbiota. Genome Res. 18(7), 1043-1050 (2008).
25. Burian M, Rautenberg M, Kohler T et al. Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J. Infect. Dis. 201(9), 1414-1421 (2010).
26. Burian M, Wolz C, Goerke C. Regulatory adaptation of Staphylococcus aureus during nasal colonization of humans. PLoS ONE 5(3), e10040 (2010).
27. Weidenmaier C, Kokai-Kun J, Kristian S et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10(3), 243-245 (2004).
28. Weidenmaier C, Kokai-Kun J, Kulauzovic E et al. Differential roles of sortase-Anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298(5-6), 505-513 (2008).
29. Heilmann C. Adhesion mechanisms of staphylococci. Bacterial Adhesion: Chem. Biol. Phys. 715, 105-123 (2011).
30. Ben Zakour N, Guinane C, Fitzgerald J. Pathogenomics of the staphylococci: Insights into niche adaptation and the emergence of new virulent strains. FEMS Microbiol. Lett. 289(1), 1-12 (2008).
31. Roche F, Meehan M, Foster T. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology SGM 149, 2759-2767 (2003).
32. Macintosh R, Brittan J, Bhattacharya R et al. The terminal A domain of the fibrillar accumulation-Associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. J. Bacteriol. 191(22), 7007-7016 (2009).
33. Brooker B, Fuller R. The adhesion of coagulase negative staphylococci to human skin and its relevance to the bacterial flora of milk. J. Appl. Bacteriol. 57(2), 325-332 (1984).
34. Kassar S, Charfeddine C, Zribi H et al. Immunohistological study of involucrin expression in Darier's disease skin. J. Cutan. Pathol. 35(7), 635-640 (2008).
35. Woolley K, Kelly R, Fazakerley J, Williams N, Nuttall T, McEwan N. Reduced in vitro adherence of Staphylococcus species to feline corneocytes compared with canine and human corneocytes. Vet. Dermatol. 19(1), 1-6 (2008).
36. McEwan N, Mellor D, Kalna G. Adherence by Staphylococcus intermedius to canine corneocytes: A preliminary study comparing noninflamed and inflamed atopic canine skin. Vet. Dermatol. 17(2), 151-154 (2006).
37. Cho S, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J. Allergy Clin. Immunol. 108(2), 269-274 (2001).
38. Morizane S, Yamasaki K, Kabigting F, Gallo R. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D-3, and retinoic acid. J. Invest. Dermatol. 130(5), 1297-1306 (2010).
39. Ali R, Falconer A, Ikram M, Bisset C, Cerio R, Quinn A. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J. Invest. Dermatol. 117(1), 106-111 (2001).
40. Murakami M, Ohtake T, Dorschner R, Schittek B, Garbe C, Gallo R. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119(5), 1090-1095 (2002).
41. Rieg S, Steffen H, Seeber S et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J. Immunol. 174, 8003-8010 (2005).
42. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3(9), 710-720 (2003).
43. Senyurek I, Paulmann M, Sinnberg T et al. Dermcidin-derived peptides show a different mode of action than the cathelicidin LL37 against Staphylococcus aureus. Antimicrob. Agents Chemother. 53(6), 2499-2509 (2009).
44. Paulmann M, Arnold T, Linke D et al. Structure-Activity analysis of the dermcidin-derived peptide DCD1L, an anionic antimicrobial peptide present in human sweat. J. Biol. Chem. 287(11), 8434-8443 (2012).
45. Song C, Weichbrodt C, Salnikov E et al. Crystal structure and functional mechanism of a human antimicrobial membrane channel. PNAS 110(12), 4586-4591 (2013).
46. Chen V, France D, Martinelli G. De nevo synthesis of lysozyme by human epidermal cells. J. Invest. Dermatol. 87(5), 585-587 (1986).
47. Bera A, Herbert S, Jakob A, Vollmer W, Gotz F. Why are pathogenic staphylococci so lysozyme resistant?. The peptidoglycan O-Acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 55(3), 778-787 (2005).
48. Herbert S, Bera A, Nerz C et al. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3(7), 981-994 (2007).
49. Gupta S, Haigh B, Griffin F, Wheeler T. The mammalian secreted RNases: Mechanisms of action in host defence. Innate Immunol. 19(1), 86-97 (2013).
50. Simanski M, Dressel S, Glaeser R, Harder J. RNase 7 protects healthy skin from Staphylococcus aureus colonization. J. Invest. Dermatol. 130(12), 2836-2838 (2010).
51. Harder J, Schroder J. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277(48), 46779-46784 (2002).
52. Hooper L, Stappenbeck T, Hong C, Gordon J. Angiogenins: A new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4(3), 269-273 (2003).
53. Cho S, Beintema J, Zhang J. The ribonuclease A superfamily of mammals and birds: Identifying new members and tracing evolutionary histories. Genomics 85(2), 208-220 (2005).
54. Avdeeva S, Chernukha M, Shaginyan I, Tarantul V, Naroditsky B. Human angiogenin lacks specific antimicrobial activity. Curr. Microbiol. 53(6), 477-478 (2006).
55. Abtin A, Eckhart L, Mildner M et al. Degradation by stratum corneum proteases prevents endogenous RNase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J. Invest. Dermatol. 129(9), 2193-2201 (2009).
56. Rendl M, Mayer C, Weninger W, Tschachler E. Topically applied lactic acid increases spontaneous secretion of vascular endothelial growth factor by human reconstructed epidermis. Br. J. Dermatol. 145(1), 3-9 (2001).
57. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J. Infect. Dis. 200(12), 1907-1915 (2009).
58. Zhang J, Dyer K, Rosenberg H. Human RNase 7: A new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res. 31(2), 602-607 (2003).
59. Huang Y, Lin Y, Chang T et al. The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J. Biol. Chem. 282(7), 4626-4633 (2007).
60. Li M, Lai Y, Villaruz A, Cha D, Sturdevant D, Otto M. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl Acad. Sci. USA 104(22), 9469-9474 (2007).
61. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H. Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology-SGM 157, 1786-1797 (2011).
62. Li M, Cha D, Lai Y, Villaruz A, Sturdevant D, Otto M. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66(5), 1136-1147 (2007).
63. Meehl M, Herbert S, Gotz F, Cheung A. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51(8), 2679-2689 (2007).
64. Falord M, Karimova G, Hiron A, Msadek T. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 56(2), 1047-1058 (2012).
65. Yang S, Bayer A, Mishra N et al. The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides. Infect. Immun. 80(1), 74-81 (2012).
66. Oku Y, Kurokawa K, Ichihashi N, Sekimizu K. Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology-SGM 150, 45-51 (2004).
67. Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 231(1), 67-71 (2004).
68. Peschel A, Jack R, Otto M et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193(9), 1067-1076 (2001).
69. Andrae J, Goldmann T, Ernst C, Peschel A, Gutsmann T. Multiple peptide resistance factor (MprF)-mediated resistance of Staphylococcus aureus against antimicrobial peptides coincides with a modulated peptide interaction with artificial membranes comprising lysyl-phosphatidylglycerol. J. Biol. Chem. 286(21), 18692-18700 (2011).
70. Perego M, Glaser P, Minutello A, Strauch M, Leopold K, Fischer W. Incorporation of d-Alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis - identification of genes and regulation. J. Biol. Chem. 270(26), 15598-15606 (1995).
71. Peschel A, Otto M, Jack R, Kalbacher H, Jung G, Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274(13), 8405-8410 (1999).
72. Lai Y, Villaruz A, Li M, Cha D, Sturdevant D, Otto M. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 63(2), 497-506 (2007).
73. Kubica M, Guzik K, Koziel J et al. A potential new pathway for Staphylococcus aureus dissemination: The silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 3(1), e1409 (2008).
74. Garzoni C, Kelley W. Staphylococcus aureus: New evidence for intracellular persistence. Trends Microbiol. 17(2), 59-65 (2009).
75. Laarman A, Ruyken M, Malone C, van Strijp J, Horswill A, Rooijakkers S. Staphylococcus aureus metalloprotease aureolysin cleaves complement C3 to mediate immune evasion. J. Immunol. 186(11), 6445-6453 (2011).
76. Kato F, Kadomoto N, Iwamoto Y, Bunai K, Komatsuzawa H, Sugai M. Regulatory mechanism for exfoliative toxin production in Staphylococcus aureus. Infect. Immun. 79(4), 1660-1670 (2011).
77. Nemoto T, Ohara-Nemoto Y, Ono T et al. Characterization of the glutamyl endopeptidase from Staphylococcus aureus expressed in Escherichia coli. FEBS J. 275(3), 573-587 (2008).
78. Hirasawa Y, Takai T, Nakamura T et al. Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J. Invest. Dermatol. 130(2), 614-617 (2010).
79. Koziel J, Potempa J. Protease-Armed bacteria in the skin. Cell Tissue Res. 351(2), 325-337 (2013).
80. Katayama Y, Baba T, Sekine M, Fukuda M, Hiramatsu K. Beta-hemolysin promotes skin colonization by Staphylococcus aureus. J. Bacteriol. 195(6), 1194-1203 (2013).
81. Ohbayashi T, Irie A, Murakami Y et al. Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology 157, 786-792 (2011).
82. Oleksy A, Golonka E, Banbula A et al. Growth phase-dependent production of a cell wall-Associated elastinolytic cysteine proteinase by Staphylococcus epidermidis. Biol. Chem. 385(6), 525-535 (2004).
83. Uehara Y, Nakama H, Agematsu K et al. Bacterial interference among nasal inhabitants: Eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J. Hosp. Infect. 44(2), 127-133 (2000).
84. Iwase T, Uehara Y, Shinji H et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465(7296), 346-349 (2010).
85. Lo C, Lai Y, Liu Y, Gallo R, Huang C. Staphylococcus aureus hijacks a skin commensal to intensify its virulence: Immunization targeting beta-hemolysin and CAMP factor. J. Invest. Dermatol. 131(2), 401-409 (2011).
86. Lai Y, Cogen A, Radek K et al. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J. Invest. Dermatol. 130(9), 2211-2221 (2010).
87. Park B, Iwase T, Liu G. Intranasal application of S. epidermidis prevents colonization by methicillin-resistant Staphylococcus aureus in mice. PLoS ONE 6(10), e25880 (2011).
88. Cogen A, Yamasaki K, Muto J et al. Staphylococcus epidermidis antimicrobial delta-Toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus. PLoS ONE 5(1), e8557 (2010).
89. Cogen A, Yamasaki K, Sanchez K et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J. Invest. Dermatol. 130(1), 192-200 (2010).
90. Periasamy S, Chatterjee S, Cheung G, Otto M. Phenol-soluble modulins in staphylococci: What are they originally for?. Commun. Integr. Biol. 5(3), 275-277 (2012).
91. Tsompanidou E, Denham E, Becher D et al. Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl. Environ. Microbiol. 79, 886-895 (2013).
92. Hachem J, Crumrine D, Fluhr J, Brown B, Feingold K, Elias P. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J. Invest. Dermatol. 121(2), 345-353 (2003).
93. Feingold K. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J. Lipid Res. 48(12), 2531-2546 (2007).
94. Hachem J, Man M, Crumrine D et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J. Invest. Dermatol. 125(3), 510-520 (2005).
95. Lampe M, Burlingame A, Whitney J et al. Human stratum corneum lipids - characterization and regional variations. J. Lipid Res. 24(2), 120-130 (1983).
96. Noble W, Valkenburg HA, Wolters C. Carriage of Staphylococcus aureus in random samples of a normal population. J. Hyg. Cambridge 65(4), 567-573 (1967).
97. Leyden J, Marples R, Kligman A. Staphylococcus aureus in lesions of atopic dermatitis. Br. J. Dermatol. 90(5), 525-530 (1974).
98. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: Colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br. J. Dermatol. 147(1), 55-61 (2002).
99. Desbois A, Smith V. Antibacterial free fatty acids: Activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 85(6), 1629-1642 (2010).
100. Galbrait H, Miller T. Effect of long-chain fatty acids on bacterial respiration and amino acid uptake. J. Appl. Bacteriol. 36(4), 659-675 (1973).
101. Greenway D, Dyke K. Mechanism of the inhibitory action of linoleic acid on the growth of Staphylococcus aureus. J. Gen. Microbiol. 115(1), 233-245 (1979).
102. Parsons J, Yao J, Frank M, Jackson P, Rock C. Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus. J. Bacteriol. 194(19), 5294-5304 (2012).
103. Arsic B, Zhu Y, Heinrichs D, McGavin M. Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS ONE 7(9), e45952 (2012).
104. Kohler T, Weidenmaier C, Peschel A. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J. Bacteriol. 191(13), 4482-4484 (2009).
105. Clarke S, Mohamed R, Bian L et al. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host Microbe 1(3), 199-212 (2007).
106. Kenny J, Ward D, Josefsson E et al. The Staphylococcus aureus response to unsaturated long-chain free fatty acids: Survival mechanisms and virulence implications. PLoS ONE 4(2), e4344 (2009).
107. King N, Sakinc T, Ben Zakour N et al. Characterisation of a cell wall-Anchored protein of Staphylococcus saprophyticus associated with linoleic acid resistance. BMC Microbiol. 12, 8 (2012).
108. Chamberlain N, Mehrtens B, Xiong Z, Kapral F, Boardman J, Rearick J. Correlation of carotenoid production, decreased membrane fluidity and resistance to oleic acid killing in Staphylococcus aureus 18Z. Infect. Immun. 59(12), 4332-4337 (1991).
109. Clauditz A, Resch A, Wieland K, Peschel A, Goetz F. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect. Immun. 74(8), 4950-4953 (2006).
110. Mishra N, Liu G, Yeaman M et al. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55(2), 526-531 (2011).
111. Chamberlain N, Brueggemann S. Characterisation and expression of fatty acid modifying enzyme produced by Staphylococcus epidermidis. J. Med. Microbiol. 46(8), 693-697 (1997).
112. Kapral F, Smith S, Lal D. The esterification of fatty acids by Staphylococcus aureus fatty acid modifying enzyme (FAME) and its inhibition by glycerides. J. Med. Microbiol. 37(4), 235-237 (1992).
113. Long J, Hart J, Albers W, Kapral F. The production of fatty acid modifying enzyme (FAME) and lipase by various staphylococcal species. J. Med. Microbiol. 37(4), 232-234 (1992).
114. Campbell I, Crozier D, Pawagi A, Buivids I. In vitro response of Staphylococcus aureus from cystic fibrosis patients to combinations of linoleic and oleic acids added to the nutrient medium. J. Clin. Microbiol. 18(2), 408-415 (1983).
115. Volkov A, Liavonchanka A, Kamneva O et al. Myosin cross-reactive antigen of Streptococcus pyogenes M49 encodes a fatty acid double bond hydratase that plays a role in oleic acid detoxification and bacterial virulence. J. Biol. Chem. 285(14), 10353-10361 (2010).
116. Pruett S, Bushnev A, Hagedorn K et al. Thematic review series: Sphingolipids - biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. J. Lipid Res. 49(8), 1621-1639 (2008).
117. Shirakura Y, Kikuchi K, Matsumura K, Mukai K, Mitsutake S, Igarashi Y. 4,8-sphingadienine and 4-hydroxy-8-sphingenine activate ceramide production in the skin. Lipids Health Dis. 11, 108 (2012).
118. Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Ichikawa Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol. 119(2), 433-439 (2002).
119. Diep B, Gill S, Chang R et al. Complete genome sequence of USA300, an epidemic clone of community-Acquired methicillin-resistant Staphylococcus aureus. Lancet 367(9512), 731-739 (2006).
120. Granslo H, Klingenberg C, Fredheim E, Ronnestad A, Mollnes T, Flaegstad T. Arginine catabolic mobile element is associated with low antibiotic resistance and low pathogenicity in Staphylococcus epidermidis from neonates. Pediatr. Res. 68(3), 237-241 (2010).
121. Thurlow L, Joshi G, Clark J et al. Functional modularity of the arginine catabolic mobile element contributes to the success of USA300 methicillin-resistant Staphylococcus aureus. Cell Host Microbe 13(1), 100-107 (2013).
122. Koskela A, Nilsdotter-Augustinsson A, Persson L, Soderquist B. Prevalence of the ica operon and insertion sequence IS256 among Staphylococcus epidermidis prosthetic joint infection isolates. Eur. J. Clin. Microbiol. Infect. Dis. 28(6), 655-660 (2009).
123. de Goffau M, Yang X, van Dijl J, Harmsen H. Bacterial pleomorphism and competition in a relative humidity gradient. Environ. Microbiol. 11(4), 809-822 (2009).
124. de Goffau M, van Dijl J, Harmsen H. Microbial growth on the edge of desiccation. Environ. Microbiol. 13(8), 2328-2335 (2011).
125. Chaibenjawong P, Foster S. Desiccation tolerance in Staphylococcus aureus. Arch. Microbiol. 193(2), 125-135 (2011).
126. Roberson E, Firestone M. Relationship between desiccation and exopolysaccharide production in a soil pseudomonas species. Appl. Environ. Microbiol. 58(4), 1284-1291 (1992).
127. Kuroda M, Tanaka Y, Aoki R, Shu D, Tsumoto K, Ohta T. Staphylococcus aureus giant protein Ebh is involved in tolerance to transient hyperosmotic pressure. Biochem. Biophys. Res. Commun. 374(2), 237-241 (2008).
128. Tsai M, Ohniwa R, Kato Y et al. Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity. BMC Microbiol. 11(13), (2011).
129. Romantsov T, Guan Z, Wood J. Cardiolipin and the osmotic stress responses of bacteria. Biochim. Biophys. Acta Biomembranes 1788(10), 2092-2100 (2009).
130. Snodgrass J, Mohamed N, Ross J, Sau S, Lee C, Smeltzer M. Functional analysis of the Staphylococcus aureus collagen adhesin B domain. Infect. Immun. 67(8), 3952-3959 (1999).
131. Hansen U, Hussain M, Villone D et al. The anchorless adhesin Eap (extracellular adherence protein) from Staphylococcus aureus selectively recognizes extracellular matrix aggregates but binds promiscuously to monomeric matrix macromolecules. Matrix Biol. 25(4), 252-260 (2006).
132. Hussain M, Becker K, von Eiff C, Schrenzel J, Peters G, Herrmann M. Identification and characterization of a novel 38.5 kilodalton cell surface protein of Staphylococcus aureus with extended spectrum binding activity for extracellular matrix and plasma proteins. J. Bacteriol. 183(23), 6778-6786 (2001).
133. Bowden M, Visai L, Longshaw C, Holland KT, Speziale P, Hook M. Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin?. J. Biol. Chem. 277(45), 43017-43023 (2002).
134. Arrecubieta C, Lee M, Macey A, Foster T, Lowy F. SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J. Biol. Chem. 282(26), 18767-18776 (2007).
135. Sakinc T, Kleine B, Gatermann S. SdrI, a serine-Aspartate repeat protein identified in Staphylococcus saprophyticus strain 7108, is a collagen-binding protein. Infect. Immun. 74(8), 4615-4623 (2006).
136. O'Brien L, Walsh E, Massey R, Peacock S, Foster T. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: Implications for nasal colonization. Cell. Microbiol. 4(11), 759-770 (2002).
137. Clarke S, Andre G, Walsh E, Dufrene Y, Foster T, Foster S. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect. Immun. 77(6), 2408-2416 (2009).
138. Heilmann C, Hartleib J, Hussain M, Peters G. The multifunctional Staphylococcus aureus autolysin Aaa mediates adherence to immobilized fibrinogen and fibronectin. Infect. Immun. 73(8), 4793-4802 (2005).
139. Hirschhausen N, Schlesier T, Schmidt M, Goetz F, Peters G, Heilmann C. A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell. Microbiol. 12(12), 1746-1764 (2010).
140. McDevitt D, Francois P, Vaudaux P, Foster T. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11(2), 237-248 (1994).
141. Ni Eidhin D, Perkins S, Francois P, Vaudaux P, Hook M, Foster T. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol. Microbiol. 30(2), 245-257 (1998).
142. Hartford O, O'Brien L, Schofield K, Wells J, Foster T. The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology 147, 2545-2552 (2001).
143. Nilsson M, Bjerketorp J, Guss B, Frykberg L. A fibrinogen-binding protein of Staphylococcus lugdunensis. FEMS Microbiol. Lett. 241(1), 87-93 (2004).
144. Wann E, Gurusiddappa S, Hook M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J. Biol. Chem. 275(18), 13863-13871 (2000).
145. Burke F, Di Poto A, Speziale P, Foster T. The A domain of fibronectin-binding protein B of Staphylococcus aureus contains a novel fibronectin binding site. FEBS J. 278(13), 2359-2371 (2011).
146. Clarke S, Wiltshire M, Foster S. IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Mol. Microbiol. 51(5), 1509-1519 (2004).
147. King N, Beatson S, Totsika M et al. UafB is a serine-rich repeat adhesin of Staphylococcus saprophyticus that mediates binding to fibronectin, fibrinogen and human uroepithelial cells. Microbiology 157, 1161-1175 (2011).
148. Heilmann C, Thumm G, Chhatwal G, Hartleib J, Uekotter A, Peters G. Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology 149, 2769-2778 (2003).
149. Hell W, Meyer H, Gatermann S. Cloning of aas, a gene encoding a Staphylococcus saprophyticus surface protein with adhesive and autolytic properties. Mol. Microbiol. 29(3), 871-881 (1998).
150. Allignet J, England P, Old I, El Solh N. Several regions of the repeat domain of the Staphylococcus caprae autolysin, At1C, are involved in fibronectin binding. FEMS Microbiol. Lett. 213(2), 193-197 (2002).
151. Williams R, Henderson B, Sharp L, Nair S. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect. Immun. 70(12), 6805-6810 (2002).
152. Nilsson M, Frykberg L, Flock J, Pei L, Lindberg M, Guss B. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect. Immun. 66(6), 2666-2673 (1998).
153. Flock J, Froman G, Jonsson K et al. Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J. 6(8), 2351-2357 (1987).
154. Jonsson K, Signas C, Muller H, Lindberg M. Two different genes encode fibronectin binding proteins in Staphylococcus aureus -The complete nucleotide sequence and characterization of the 2nd gene. Eur. J. Biochem. 202(3), 1041-1048 (1991).
155. Sakinc T, Kleine B, Michalski N, Kaase M, Gatermann S. SdrI of Staphylococcus saprophyticus is a multifunctional protein: Localization of the fibronectin-binding site. FEMS Microbiol. Lett. 301(1), 28-34 (2009).
156. Huesca M, Peralta R, Sauder D, Simor A, McGavin M. Adhesion and virulence properties of epidemic Canadian methicillin-resistant Staphylococcus aureus strain 1: Identification of novel adhesion functions associated with plasmin-sensitive surface protein. J. Infect. Dis. 185(9), 1285-1296 (2002).
157. Mulcahy M, Geoghegan J, Monk I et al. Nasal colonisation by Staphylococcus aureus depends upon clumping factor B binding to the squamous epithelial cell envelope protein loricrin. PLoS Pathog. 8(12), e1003092 (2012).
158. Corrigan R, Miajlovic H, Foster T. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol. 9 (2009).
159. Corrigan R, Rigby D, Handley P, Foster T. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 153, 2435-2446 (2007).
160. Mempel M, Schmidt T, Weidinger S et al. Role of Staphylococcus aureus surface-Associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J. Invest. Dermatol. 111(3), 452-456 (1998).
161. Wanke I, Skabytska Y, Kraft B, Peschel A, Biedermann T, Schittek B. Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local inflammation. Exp. Dermatol. 22(2), 153-155 (2013).
162. Back S, Jeong K, Li C, Lee J, Lee S, Na H. Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis. J. Dermatol. Sci. 67(2), 111-119 (2012).
163. Herz U, Schnoy N, Borelli S et al. A human-SCID mouse model for allergic immune responses: Bacterial superantigen enhances skin inflammation and suppresses IgE production. J. Invest. Dermatol. 110(3), 224-231 (1998).
164. Kiser K, Cantey-Kiser J, Lee J. Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect. Immun. 67(10), 5001-5006 (1999).